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Abstract
Acinetobacter baumannii is an emerging cause of nosocomial infections. The isolation of strains resistant to multiple
antibiotics is increasing at alarming rates. Although A. baumannii is considered as one of the more threatening ‘‘superbugs’’
for our healthcare system, little is known about the factors contributing to its pathogenesis. In this work we show that A.
baumannii ATCC 17978 possesses an O-glycosylation system responsible for the glycosylation of multiple proteins. 2D-DIGE
and mass spectrometry methods identified seven A. baumannii glycoproteins, of yet unknown function. The glycan
structure was determined using a combination of MS and NMR techniques and consists of a branched pentasaccharide
containing N-acetylgalactosamine, glucose, galactose, N-acetylglucosamine, and a derivative of glucuronic acid. A
glycosylation deficient strain was generated by homologous recombination. This strain did not show any growth defects,
but exhibited a severely diminished capacity to generate biofilms. Disruption of the glycosylation machinery also resulted in
reduced virulence in two infection models, the amoebae Dictyostelium discoideum and the larvae of the insect Galleria
mellonella, and reduced in vivo fitness in a mouse model of peritoneal sepsis. Despite A. baumannii genome plasticity, the O-
glycosylation machinery appears to be present in all clinical isolates tested as well as in all of the genomes sequenced. This
suggests the existence of a strong evolutionary pressure to retain this system. These results together indicate that O-
glycosylation in A. baumannii is required for full virulence and therefore represents a novel target for the development of
new antibiotics.
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Introduction
Acinetobacter baumannii is a strictly aerobic Gram negative, non-
fermentative, opportunistic pathogen. Since the 1970’s, this
organism has frequently been isolated from healthcare facilities,
but was easily controlled with antibiotics [1,2]. However, many
clinical isolates of A. baumannii have recently emerged with extreme
resistance to antibiotics, disinfectants, and desiccation, which has
permitted A. baumannii to disseminate throughout healthcare
facilities worldwide [3–7]. One recent study showed that from
2001 to 2008 the percentage of A. baumannii isolates resistant to at
least three classes of antibiotics increased from 4% to 55%, and
17% of all isolates were resistant to at least four drug classes [8].
Panresistant strains of A. baumannii have also been isolated [9].
Because of its importance as an emerging pathogen, attention
towards A. baumannii has increased considerably. Most of the
efforts have focused on antibiotic resistance mechanisms, but little
is known about its virulence factors. A significant amount of work
has been done to characterize biofilm formation, which seems to
play a role in pathogenesis [10,11]. Other suggested virulence
factors for A. baumannii include the capsule, exopolysaccharide, pili
and lipopolysaccharide (LPS) [11–14]. Undoubtedly, more
research is needed in order to understand A. baumannii pathogen-
esis.
Genomic analysis of all sequenced A. baumannii strains revealed
the presence of homologous genes to those encoding enzymes
involved in the Neisseria meningitidis protein O-glycosylation system.
Many different mucosal pathogenic bacteria require protein
glycosylation for virulence, and glycoproteins seem to play a role
in adhesion, motility, DNA uptake, protein stability, immune
evasion, and animal colonization [15]. Whereas N-glycosylation
seems to be restricted to epsilon and a few delta proteobacteria, O-
glycosylation appears to be more widespread among bacteria.
Gram negative bacteria including Neisseria spp. and Bacteroides
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multiple proteins [16,17]. En bloc O-glycosylation is initiated by a
specialized glycosyltransferase that attaches a nucleotide-activated
monosaccharide-1P to an undecaprenolphosphate (Und-P) lipid
carrier on the inner face of the inner membrane. A series of
glycosyltransferases subsequently attach additional monosaccha-
rides to the first sugar residue on Und-PP. When the carbohydrate
structure is completed, the Und-PP linked glycan is flipped to the
periplasmic face, where an O-oligosaccharyltransferase (O-OTase)
transfers the carbohydrate to selected Ser or Thr residues in
acceptor proteins [18,19]. Campylobacter jejuni employs a similar N-
glycosylation pathway to modify about 65 proteins [20].
This work demonstrates the existence of a general O-glycosyl-
ation system in A. baumannii ATCC 17978, which is required for
efficient biofilm formation and pathogenesis in the Dictyostelium
discoideum, Galleria mellonella, and murine septicemia virulence
models. We identified seven glycoproteins carrying a branched
pentasaccharide, the structure of which has been characterized by
MS and NMR techniques. O-glycosylation appears to be
ubiquitous in A. baumannii, which suggests that this system might
be a possible target for novel antimicrobial treatments.
Results
Identification of an O-OTase homologue in A. baumannii
and construction of an in-frame knockout mutant
We initially searched the A. baumannii ATCC 17978 genome for
homologues of known O-OTases. Via a BLAST analysis, we
identified a homolog to the N. meningitidis O-OTase PglL
(A1S_3176; E-value 1e-9) that contained a Wzy_C motif. This
motif is conserved in all O-OTases, but is also found in WaaL
ligases, which catalyze the transfer of the O antigen to the Lipid A
core [21,22]. To date, only experimental determination allows the
assignment of an ORF containing the Wzy_C motif as either an O-
OTase or a ligase [23]. No other ORFs contained a Wzy_C motif
in the A. baumannii ATCC 17978 genome. A1S_3176 is not
predicted to be part of an operon [24]. We carried out
mutagenesis of the A1S_3176 gene by homologous recombination
to evaluate if its encoded protein is an O-Otase or a WaaL ligase.
PCR and DNA sequencing confirmed the creation of an
A1S_3176 knockout strain, in which the targeted gene was
replaced with a gentamicin resistance cassette. There was no
significant difference between the growth curves of the wild-type
and the A1S_3176 mutant strains at 37uC, indicating that growth
in these conditions was not affected by the mutation (Data not
shown).
A1S_3176 (PglLAb) is required for glycosylation of
membrane proteins in A. baumannii ATCC 17978
Most of the Neisseria O-glycoproteins identified to date are
associated to membranes [16]. Membrane extracts from wild type
and DA1S_3176 A. baumannii strains were analyzed by SDS-PAGE
followed by PAS staining, a technique that is specific for detecting
glycans, but presents low sensitivity (Fig. 1). A broad band
migrating from 25 to 35 kDa was visualized in the extract of A.
baumannii WT. Although the membrane protein profile between
the WT and the DA1S_3176 strains appeared similar, the band
detected via PAS stain was not visible in the mutant strain,
suggesting that A1S_3176 is required for glycosylation of at least
one protein (Fig. 1B). The PAS-reactive band disappeared upon
treatment with proteinase K, associating the glycan signal with
proteinaceous material. Complementation of A1S_3176 was
achieved in trans, and analysis of A. baumannii DA1S_3176-
pWH1266-pglL membrane extract showed the reappearance of
the PAS stained band. Due to the aforementioned similarity
between O-OTases and ligases, we carried out a conventional LPS
extraction and analyzed the extract of the different strains via
SDS-PAGE. Silver stain showed no obvious differences in the
carbohydrate pattern were observed, suggesting that A1S_3176 is
not involved in LPS synthesis (Fig S1). To further determine if
A1S_3716 effected LPS biosynthesis, whole cells were digested
with proteinase K and analyzed by Silver stain and no differences
were observed (data not shown). However, it has been reported
that the O-antigen chains of certain A. baumannii strains are not
detectable by Silver stain and therefore we cannot conclusively
exclude a role of A1S_3176 in LPS synthesis [25]. Together these
results suggest that A1S_3176 is an O-OTase responsible for O-
Figure 1. A. baumannii requires PglLAb to glycosylate mem-
brane proteins. 10 mg of membrane extract from A. baumannii strains
(lanes 1,2,3,4) were resolved by SDS-PAGE. A) Carbohydrates were
detected by PAS stain. B) Proteins were detected by Coomassie
staining. Samples were as follows: lane 1 WT; lane 1a Proteinase K
treated WT; lane 2 DpglL, lane 3 DpglL, pWH1266-pglL,4 - DpglL,
pWH1266 control.
doi:10.1371/journal.ppat.1002758.g001
Author Summary
Multidrug resistant (MDR) Acinetobacter baumannii strains
are an increasing cause of nosocomial infections world-
wide. Due to the remarkable ability of A. baumannii to gain
resistance to antibiotics, this bacterium is now considered
to be a ‘‘superbug’’. A. baumannii strains resistant to all
clinically relevant antibiotics known have also been
isolated. Although MDR A. baumannii continues to
disseminate globally, very little is known about its
pathogenesis mechanisms. Our experiments revealed that
A. baumannii ATCC 17978 has a functional O-linked protein
glycosylation system, which seems to be present in all
strains of A. baumannii sequenced to date and several
clinical isolates. We identified seven glycoproteins and
elucidated the structure of the glycan moiety. A glycosyl-
ation-deficient strain was generated. This strain produced
severely reduced biofilms, and exhibited attenuated
virulence in amoeba, insect, and murine models. These
experiments suggest that glycosylation may play an
important role in virulence and may lay the foundation
for new drug discovery strategies that could stop the
dissemination of this emerging human pathogen, which
has become a major threat for healthcare systems.
O-glycosylation in Acinetobacter baumannii
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PglLAb, as per its N. meningitidis ortholog.
Identification of two glycoproteins in A. baumannii via
2D-DIGE and preliminary characterization of the O-glycan
by MALDI-TOF/TOF MS and MS/MS analysis
To identify the glycoprotein(s) in A. baumannii, we performed two
dimensional in-gel electrophoresis (2D-DIGE) experiments [26].
Membrane samples of both WT and DpglL were isolated by
ultracentrifugation and the lipidic components were removed as
previously described [27]. Most of the signals corresponding to the
wild type (Fig. 2A, green) and DpglL (Fig. 2B, red) proteins co-
localized in the gel (Fig. 2C, yellow), indicating that these proteins
were likely not glycosylated. However, a few proteins exhibited
differential electrophoretic behavior (Fig. 2). These proteins spots
were excised, in-gel digested, and analyzed by MALDI-TOF/
TOF MS and MS/MS. We identified two separate pairs of
proteins, which according to their electrophoretic migration,
appeared to be larger and more acidic in the WT strain (WT1 and
WT2) than in the DpglL strain (MT1 and MT2). Mass
spectrometric analysis determined WT1 and MT1 samples to be
A1S_3626 protein, whereas WT2 and MT2 were identified as
A1S_3744 protein. Both, A1S_3626 and A1S_3744 are annotated
as hypothetical proteins, and BLAST searches yielded homologues
exclusively within the Acinetobacter genus.
Analysis of the MALDI-TOF MS spectra of a tryptic digest of
WT1 (A1S_3626) revealed a peptide fragment of 2895.24 Da that
was absent in MT1 (Fig. 3A). MALDI-TOF-TOF MS/MS of this
ion determined that in the wild-type strain the peptide
SAGDQAASDIATATDNASAK was linked to the glycan Hex-
NAc-Hex-Hex-(HexNAc)-300, where 300 corresponded to an
unknown residue of m/z 300, whereas the same peptide was
unmodified in DpglL sample (Fig S3A). Similarly, MALDI-TOF
MS analysis of a tryptic digest of WT2 (A1S_3744) revealed a
peptide fragment of 3852.69 Da that was absent in MT2 (Fig. 3B).
MALDI-TOF-TOF MS/MS of the 3852.69 Da peak revealed the
same pentasaccharide identified on A1S_3626 on the peptide
ETPKEEEQDKVETAVSEPQPQKPAK (2822.33 Da), whereas
the same peptide was unmodified in DpglL sample (Fig S3B).. We
next purified membranes from A. baumannii, digested the sample
with Pronase E, and enriched glycosylated peptides using activated
charcoal microspin columns. We identified a peak in the MALDI-
TOF MS of 1358.4 m/z that was subsequently analyzed by
MALDI-TOF/TOF MS/MS (Fig. 3C). Manual peak annotation
identified the previously characterized pentasaccharide attached to
a sodiated tripeptide containing the amino acids A, T and D.
Overall, these results demonstrate that PglLAb glycosylates at
least two different proteins with a pentasaccharide with a
preliminary structure of HexNAc-Hex-Hex-(HexNAc)-300.
We observed other spots possibly corresponding to proteins
migrating differently in A. baumannii WT and DpglL strains. The
most prominent was marked as WT3, and was observed only in
the WT extract (Fig. 2C). Mass spectroscopy analysis deter-
mined this spot corresponded to OmpA (A1S_2840). However,
manual analysis using MS/MS of WT3 indicated that OmpA
was not glycosylated. Western blot analysis of whole cell
extracts of the WT and DpglL strains revealed no difference in
OmpA expression levels, which implies that manipulation of
membrane samples could account for apparent differences
observed in expression levels of proteins detected by 2D-DIGE
(Fig S2).
Identification of additional O-glycosylated proteins in A.
baumannii ATCC 17978 by zwitterionic hydrophilic
interaction chromatography (ZIC-HILIC) MS/MS
To determine if additional glycoproteins were present in A.
baumannii ATCC 17978, we employed ZIC-HILIC glycopeptide
enrichment. Utilizing membrane extracts previously shown to
contain A1S_3626 and A1S_3744 putative glycopeptides were
enriched and analyzed using an LTQ-Orbitrap Velos. HCD
scans containing oxonium ion were manually inspected and
searched using MASCOT resulting in the identification of at
least 9 different glycosylation sites on 7 different glycoproteins in
A. baumannii ATCC 17978 (Table 1; Fig. 4). This peptide-centric
approach enabled multiple novel glycoproteins to be identified of
which six of the seven proteins are annotated as uncharacterized
hypothetical proteins, with the remaining being annotated as
MotB (A1S_1193). (Table 1). This demonstrates that PglLAb is
able to glycosylate multiple proteins in A. baumannii ATCC
17978.
Structure determination of the O-linked glycan by 2D
NMR
Identification of the O-glycan of A. baumannii ATCC 17978 was
achieved by 2D NMR analysis. The Pronase E digested
membrane protein extracts characterized in Fig. 3C were analyzed
by
1H:
13C HSQC 2D NMR and revealed the structure of the
pentasaccharide to be b-GlcNAc3NAcA4OAc-4-(b-GlcNAc-6-)-a-
Gal-6-b-Glc-3-b-GalNAc-, with the amino acids S, E, and A
attached in any combination (Fig S4, Table 2). b-GlcNAc3NA-
cA4OAc (corresponding to m/z 300; Fig. 3) is an O-acetylated
derivative of glucuronic acid, and can account for the more acidic
migration of the WT glycoproteins compared to the DpglL in the
2D-DIGE analysis.
Figure 2. Comparison of A. baumannii WT and DpglL membrane extracts by 2D-DIGE. Analysis of the membrane proteome of A. baumannii
WT strain (A), DpglL strain (B), and merge (C). Spots WT1 and WT2 only present in the WT strain (green) whereas MT1 and MT2 were only present in
the DpglL strain (red). MALDI-TOF MS analysis identified WT1 and MT1 spots as A1S_3626 protein and WT2 and MT2 spots as A1S_3744 protein.
doi:10.1371/journal.ppat.1002758.g002
O-glycosylation in Acinetobacter baumannii
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It has been suggested that biofilm formation is important for A.
baumannii virulence [28]. We tested if O-glycosylation has an
impact on biofilm formation in this organism. Biofilm formation
was detected using crystal violet staining and quantitatively
analyzed by comparing the ratio between cell growth (OD600)
and biofilm formation (OD580)a t3 0 uC after 48 hours incubation
(Fig. 5A). High absorbance values corresponding to a strong ability
to create biofilms (1.2360.48 and 1.1260.40) were obtained for
the WT strain and the DpglL strain complemented in trans
respectively. On the contrary, the DpglL strain and the DpglL strain
transformed with pWH1266 exhibited severely reduced levels of
absorbance (0.1860.07 and 0.2060.04). Similar results were also
observed at 37uC (data not shown). We further characterized the
role of O-glycosylation in biofilm formation by employing a flow
cell system. A. baumannii strains were stained with the green
fluorescent stain SYTO 9, visualized by confocal laser scanning
microscopy, and quantitative analysis of the biofilms was
performed with COMSTAT. Assessment of the initial attachment
after 2 hours shows that DpglL strain and vector control had
significantly less surface coverage (4.12% and 2.32% respectively)
than the WT and in trans complemented strain (6.41% and 6.45%
respectively; Fig. 5B). Confocal microscopy and subsequent
analysis of biofilms biomass, as well as average and maximal
thickness after 24 hours showed significantly higher levels for the
WT compared to the DpglL strain, and the phenotype was restored
to WT levels when pglLAb was complemented in trans (Fig. 5 C, D,
E, F; *P,0.05). These data indicate that the A. baumannii strain
Figure 3. MS/MS of A1S_3626 and A1S_3744 showing glycosylation in A. baumannii with a pentasaccharide. Spots excised from the 2D
DIGE, digested with trypsin, and analyzed by MALDI-TOF-MS. Peaks not corresponding to peptide fragmentation were analyzed for glycosylation. A)
MS/MS of the precursor ion peak at m/z 2895.165 from A1S_3626 revealed the peptide SAGDQAASDIATATDNASAK with a pentasaccharide of
HexNAc-Hex-Hex-(HexNAc)-300 attached. B) MS/MS of the precursor ion peak at m/z 3852.76 from A1S_3744 revealed the peptide
ETPKEEEQDKVETAVSEPQPQKPAK with the same pentasaccharide attached. C) MALDI-TOF MS of Pronase E digested membrane proteins
showed a precursor ion peak of m/z 1358.4 which MS/MS analysis demonstrated to be the previously identified O-glycan (HexNAc-Hex-Hex-(HexNAc)-
300 attached to the peptide fragment ‘‘ATD’’.
doi:10.1371/journal.ppat.1002758.g003
O-glycosylation in Acinetobacter baumannii
PLoS Pathogens | www.plospathogens.org 4 June 2012 | Volume 8 | Issue 6 | e1002758T
a
b
l
e
1
.
I
d
e
n
t
i
f
i
c
a
t
i
o
n
o
f
s
e
v
e
n
O
-
g
l
y
c
o
s
y
l
a
t
e
d
p
r
o
t
e
i
n
s
w
i
t
h
n
i
n
e
u
n
i
q
u
e
g
l
y
c
o
s
y
l
a
t
i
o
n
s
i
t
e
s
b
y
Z
I
C
H
I
L
I
C
e
n
r
i
c
h
m
e
n
t
o
f
t
r
y
p
t
i
c
a
l
l
y
d
i
g
e
s
t
e
d
A
.
b
a
u
m
a
n
n
i
i
A
T
C
C
1
7
9
7
8
m
e
m
b
r
a
n
e
e
x
t
r
a
c
t
s
.
P
r
e
c
u
r
s
o
r
m
/
z
[
D
a
]
M
H
+
[
D
a
]
C
h
a
r
g
e
P
e
p
t
i
d
e
m
a
s
s
[
D
a
]
M
a
s
c
o
t
I
o
n
s
c
o
r
e
S
e
q
u
e
n
c
e
p
r
o
t
e
i
n
n
a
m
e
A
n
n
o
t
a
t
i
o
n
f
o
r
A .
b a u m a n n i i
A
T
C
C
1
7
9
7
8
7
4
9
.
0
2
2
2
4
5
.
0
4
0
3
1
2
1
4
.
6
8
3
1
3
0
1
A
K
P
A
S
T
P
A
V
K
S
A
S
3
1
3
P
u
t
a
t
i
v
e
u
n
c
h
a
r
a
c
t
e
r
i
z
e
d
p
r
o
t
e
i
n
A
1
S
_
0
5
5
6
1
0
0
0
.
4
7
1
9
9
9
.
9
4
3
2
9
6
9
.
5
7
4
9
3
0
1
A
K
P
A
S
T
P
A
V
K
3
1
0
P
u
t
a
t
i
v
e
u
n
c
h
a
r
a
c
t
e
r
i
z
e
d
p
r
o
t
e
i
n
A
1
S
_
0
5
5
6
9
9
9
.
9
5
3
9
9
6
.
7
9
4
4
2
9
6
6
.
4
1
4
0
1
0
8
A
A
Q
A
D
K
K
T
E
A
S
A
A
A
T
T
E
Q
Q
D
S
F
D
A
Q
V
Q
R
1
3
5
P
u
t
a
t
i
v
e
u
n
c
h
a
r
a
c
t
e
r
i
z
e
d
p
r
o
t
e
i
n
A
1
S
_
0
5
5
6
1
0
9
0
.
5
3
5
4
4
8
.
6
3
1
5
4
4
1
8
.
2
1
3
9
2
0
3
A
A
S
G
V
E
A
A
A
A
P
A
T
L
T
L
S
T
D
D
K
G
A
V
S
Q
C
Q
A
G
I
G
D
Q
G
F
L
A
T
L
Q
T
Q
V
K
2
4
7
O
m
p
A
/
M
o
t
B
A
1
S
_
1
1
9
3
1
1
4
4
.
2
0
3
4
3
0
.
5
8
7
3
2
4
0
0
.
2
0
8
1
7
8
N
L
Q
K
A
E
D
Q
N
A
D
S
G
I
A
A
S
T
P
V
A
T
A
K
1
0
1
P
u
t
a
t
i
v
e
u
n
c
h
a
r
a
c
t
e
r
i
z
e
d
p
r
o
t
e
i
n
A
1
S
_
2
3
7
1
1
3
4
4
.
6
4
4
0
3
1
.
8
9
9
3
3
0
0
1
.
5
1
8
6
7
2
A
S
T
T
L
Q
N
L
Q
K
A
E
D
Q
N
A
D
S
G
I
A
A
S
T
P
V
A
T
A
K
1
0
1
P
u
t
a
t
i
v
e
u
n
c
h
a
r
a
c
t
e
r
i
z
e
d
p
r
o
t
e
i
n
A
1
S
_
2
3
7
1
1
4
6
9
.
0
5
4
4
0
5
.
1
3
2
3
3
3
7
4
.
7
3
5
1
2
2
A
S
T
T
E
Q
P
L
N
P
N
K
V
S
A
P
V
E
D
P
I
D
P
L
A
V
D
A
A
S
T
V
K
5
4
P
u
t
a
t
i
v
e
u
n
c
h
a
r
a
c
t
e
r
i
z
e
d
p
r
o
t
e
i
n
A
1
S
_
2
3
7
1
1
2
1
0
.
5
2
2
4
2
0
.
0
3
7
2
1
3
8
9
.
6
6
5
3
5
2
S
D
A
V
G
S
A
S
E
A
A
P
A
T
R
6
6
P
u
t
a
t
i
v
e
u
n
c
h
a
r
a
c
t
e
r
i
z
e
d
p
r
o
t
e
i
n
A
1
S
_
3
5
8
0
1
2
8
1
.
5
6
2
5
6
2
.
1
1
5
2
1
5
3
1
.
7
3
7
4
5
0
A
A
S
D
A
V
G
S
A
S
E
A
A
P
A
T
R
6
6
P
u
t
a
t
i
v
e
u
n
c
h
a
r
a
c
t
e
r
i
z
e
d
p
r
o
t
e
i
n
A
1
S
_
3
5
8
0
1
2
8
3
.
0
6
2
5
6
5
.
1
1
1
2
1
5
3
4
.
7
3
4
7
5
2
Q
A
A
S
D
I
A
T
A
T
D
N
A
S
A
K
6
7
P
u
t
a
t
i
v
e
u
n
c
h
a
r
a
c
t
e
r
i
z
e
d
p
r
o
t
e
i
n
A
1
S
_
3
6
2
6
1
4
0
6
.
6
2
4
2
1
7
.
8
5
6
3
3
1
8
7
.
4
6
7
7
4
8
S
A
G
D
Q
A
A
S
D
I
A
T
A
T
D
N
(
+
1
)
A
S
A
K
I
D
A
A
A
D
H
A
A
D
A
T
A
K
8
1
P
u
t
a
t
i
v
e
u
n
c
h
a
r
a
c
t
e
r
i
z
e
d
p
r
o
t
e
i
n
A
1
S
_
3
6
2
6
9
6
5
.
7
5
2
8
9
5
.
2
5
2
3
1
8
6
4
.
8
5
5
1
4
8
S
A
G
D
Q
A
A
S
D
I
A
T
A
T
D
N
A
S
A
K
6
7
P
u
t
a
t
i
v
e
u
n
c
h
a
r
a
c
t
e
r
i
z
e
d
p
r
o
t
e
i
n
A
1
S
_
3
6
2
6
1
0
5
4
.
9
8
4
2
1
6
.
8
9
0
4
3
1
8
6
.
4
8
6
6
4
8
S
A
G
D
Q
A
A
S
D
I
A
T
A
T
D
N
A
S
A
K
I
D
A
A
A
D
H
A
A
D
A
T
A
K
8
1
P
u
t
a
t
i
v
e
u
n
c
h
a
r
a
c
t
e
r
i
z
e
d
p
r
o
t
e
i
n
A
1
S
_
3
6
2
6
7
5
5
.
5
4
3
0
1
9
.
1
4
6
4
1
9
8
8
.
7
7
2
4
2
8
N
D
G
M
(
+
1
6
)
H
E
A
S
D
P
A
T
S
H
D
M
(
+
1
6
)
N
K
4
5
P
u
t
a
t
i
v
e
u
n
c
h
a
r
a
c
t
e
r
i
z
e
d
p
r
o
t
e
i
n
A
1
S
_
3
6
5
8
9
9
6
.
3
9
2
9
8
7
.
1
5
8
3
1
9
5
6
.
7
8
8
0
2
8
N
D
G
M
H
E
A
S
D
P
A
T
S
H
D
M
N
K
4
5
P
u
t
a
t
i
v
e
u
n
c
h
a
r
a
c
t
e
r
i
z
e
d
p
r
o
t
e
i
n
A
1
S
_
3
6
5
8
7
9
7
.
8
1
3
1
8
8
.
2
3
3
4
2
1
5
7
.
8
6
2
2
2
8
N
D
G
M
H
E
A
S
D
P
A
T
S
H
D
M
N
K
N
S
4
7
P
u
t
a
t
i
v
e
u
n
c
h
a
r
a
c
t
e
r
i
z
e
d
p
r
o
t
e
i
n
A
1
S
_
3
6
5
8
1
0
0
1
.
7
2
3
0
0
3
.
1
5
3
3
1
9
7
2
.
7
8
4
2
2
8
N
D
G
M
(
+
1
6
)
H
E
A
S
D
P
A
T
S
H
D
M
N
K
4
5
P
u
t
a
t
i
v
e
u
n
c
h
a
r
a
c
t
e
r
i
z
e
d
p
r
o
t
e
i
n
A
1
S
_
3
6
5
8
1
1
3
3
.
1
8
3
3
9
7
.
5
3
8
3
2
3
6
7
.
1
7
4
4
2
9
E
E
E
Q
D
K
V
E
T
A
V
S
E
P
Q
P
Q
K
P
A
K
4
9
P
u
t
a
t
i
v
e
u
n
c
h
a
r
a
c
t
e
r
i
z
e
d
p
r
o
t
e
i
n
A
1
S
_
3
7
4
4
8
8
0
.
4
2
2
6
3
9
.
2
3
2
3
1
6
0
8
.
8
6
5
5
3
5
V
E
T
A
V
S
E
P
Q
P
Q
K
P
A
K
4
9
P
u
t
a
t
i
v
e
u
n
c
h
a
r
a
c
t
e
r
i
z
e
d
p
r
o
t
e
i
n
A
1
S
_
3
7
4
4
d
o
i
:
1
0
.
1
3
7
1
/
j
o
u
r
n
a
l
.
p
p
a
t
.
1
0
0
2
7
5
8
.
t
0
0
1
O-glycosylation in Acinetobacter baumannii
PLoS Pathogens | www.plospathogens.org 5 June 2012 | Volume 8 | Issue 6 | e1002758defective in O-glycosylation has a severely diminished capacity to
form biofilms.
PglLAb is required for virulence towards Dictyostelium
discoideum, and Galleria mellonella
Two well-established virulence models for A. baumannii are the
D. discoideum predation and the G. mellonella infection models [5,29–
33]. D. discoideum is an unicellular amoeba that feeds on bacteria
and previous work has demonstrated similarity between phagocy-
tosis of the amoebae and mammalian phagocytes [34]. We
examined if protein glycosylation was required for virulence
towards D. discoideum by co-incubation of A. baumannii strains with
the amoebae on SM/5 nutrient agar. A. baumannii was previously
shown to inhibit amoebae growth in the presence of 1% ethanol
[5]. The WT strain was virulent and inhibited all D. discoideum
growth in the presence of 1% ethanol, which resulted in no plaque
being formed. However the DpglL strain was avirulent towards the
amoeba, which resulted in plaque formation in the bacterial lawn
within 48 hours and clearing of the plate within 4–5 days (Fig S5).
G. mellonella have been used to study many host-pathogen
interactions, and have several advantages over other virulence
models including the presence of both humoral (ie. antimicrobial
peptides) and cellular immune response systems (phagocytic cells)
[32]. Most importantly, a correlation has been established between
the virulence of several bacteria in G. mellonella and mammalian
models [35,36]. For the G. mellonella, while a similar bacterial load
(2.3161.13610
5 CFU) was injected for each of the strains, only
the WT and complemented strains were able to kill the wax moth
larvae after 36 hours, (20% and 0% survival), whereas larvae
injected with DpglL and the DpglL vector control strains had
significantly higher survival rates (100% and 80%; Fig. 6). The
LD50 of the WT and complemented strains were determined to be
approximately 2.6610
4 and 1.4610
4 respectively after 36 hours.
No additional killing was observed in the DpglL or vector control
strains up to 96 hours. A PBS injected control maintained 100%
survival throughout the length of the virulence assay. These results
demonstrate a critical role for O-glycosylation in the virulence of A.
baumannii in these two model systems.
PglLAb is required for competitive fitness in BALB/c mice
We then tested A. baumannii DpglL virulence in vivo using a
previously described murine septicemia competition model [37–
39]. We first determined the LD50 of A. baumannii ATCC 17978
strain by injecting groups of 5 BALB/c mice with serially diluted
bacteria cultures (Fig. 7A). A very small dose range between full
survival and full killing was observed, and the LD50 was
determined to be 6.49610
4 CFU/mouse. The competition index
(CI) was defined as the number of DpglL CFUs recovered/number
of WT CFUs recovered, divided by the number of DpglL CFUs
inoculated/number of WT CFUs inoculated. Cultures of each
Figure 4. Identification of additional glycoproteins in A. baumannii ATCC 17978. Tryptically digested membranes were enriched via ZIC-
HILIC and analyzed by LC-MS and HCD MS-MS. All spectra were analyzed for the diagnostic oxonium ion of 301.10 m/z, and positive spectra were
analyzed manually to identify the glycopeptide. This spectra is representative of each glycopeptide identified in Table 2. A) ITMS-CID of the precursor
ion at m/z 1999.943 reveals the pentasaccharide attached to the peptide AKPASTPAVK. B) FTMS-HCD of the precursor ion at m/z 1999.943 reveals
the peptide sequence AKPASTPAVK.
doi:10.1371/journal.ppat.1002758.g004
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determine the initial CI. 1610
5 CFU of the mixed strains were
injected intraperitoneally into the BALB/c mice, which were
subsequently sacrificed 18 hrs post injection. The spleens were
aseptically harvested, serial diluted, and plated. All of the mice had
a high spleen CFU load of 3.7562.37610
8 CFU/gram and were
moribund at the time of sacrifice. While the initial prescreen
showed a CI of 1.1860.21 favoring the DpglL mutant, the spleen
counts after 18 hrs showed a CI of 0.1060.03 (Fig. 7B). This data
suggests that Ab DpglL has a competitive disadvantage as
compared to the WT strain. Together, these results indicate that
A. baumannii strains lacking O-glycosylation are attenuated in mice.
Protein glycosylation appears to be ubiquitous in
Acinetobacter sp.
To determine the degree of conservation of the O-glycosylation
system in Acinetobacter sp., we searched for the presence of PglLAb
homologues in different species within the genus. This genomic
search showed that PglLAb was present in all the genomes analyzed
with high sequence homology (Fig S6A). We obtained eight
clinical isolates from the University of Alberta Hospital. The
isolates were identified by 16S rDNA and recA sequencing to be
different species within the Acinetobacter genus (A. baumannii, A.
nosocomialis, A. pittii, and A. calcoaceticus). Membranes of these strains
were purified and analyzed by PAS staining for the presence of
glycoproteins (Fig S6B). While there appears to be variation in the
size and intensity of the PAS stained band, all the isolates were
positive for glycoproteins, demonstrating that PglLAb was active in
all these strains. This indicates that despite the plasticity of
Acinetobacter sp. genomes [40], there is a strong evolutionary
pressure to retain a functional O-glycosylation system.
Discussion
Isolation of MDR strains of A. baumannii is increasing at
impressive rates. Despite its growing incidence as nosocomial
pathogen, only a few A. baumannii virulence factors have been
characterized. In this article we describe a general O-glycosylation
system in A. baumannii ATCC 17978. Although once considered
rare in prokaryotes, both N- and O-glycoproteins are present in all
domains of life. In most bacterial species known to synthesize
glycoproteins, glycosylation is restricted to a few proteins including
adhesins, flagellins or pilins [15]. Only a few ‘‘general’’ glycosyl-
ation systems in which more than a single protein is glycosylated
have been characterized. C. jejuni N-glycosylates more than 65
proteins with the same heptasaccharide. Inactivation of the
glycosylation pathway does not have an effect on growth in vitro,
but does reduce adhesion and invasion to cells in culture, and
affects chicken and mice colonization [41]. Neisseria gonorrhoeae is
able to O-glycosylate at least 12 proteins with a highly variable
glycan structure [42]. The glycan has recently been shown to be
important for infection of cervical epithelial cells [43]. Bacteroides
fragilis also has a general O-glycosylation system, where hundreds
of proteins are predicted to be glycosylated [44]. Inactivation of
the glycosylation system results in severe growth defects in vitro
[17]. It was then not surprising to see that the glycosylation mutant
strain was outcompeted by the wild-type strain in gnotobiotic mice
colonization experiments. Seven proteins are shown to be O-
glycosylated by the PglL OTase encoded by the A1S_3176 gene.
Cells unable to perform protein glycosylation do not show any
differential growth phenotype in vitro, while exhibiting a dimin-
ished capacity to form biofilms and reduced virulence in D.
discoideum, G. mellonella, and murine septicemia pathogenesis
models systems.
Table 2.
1H:
13C HSQC 2D NMR data for the characterization of the A. baumannii 17978 O-glycan.
Unit H/C-1 H/C-2 H/C-3 H/C-4 H/C-5 H/C-6a;b
Gal A H 4.95 3.68 3.94 4.12 4.02 3.78; 4.12
C 99.3 69.8 70.6 79.1 70.8 72.3
GlcNNA B H 4.84 3.92 4.20 4.96 3.99
C 103.4 54.5 53.9 71.9 76.0 174.4
GlcNNA B9 H 4.81 3.79 3.99 3.64 3.88
C 103.5 55.0 56.1 71.1
GalNAc C H 4.58 4.07 3.87 4.14 3.70 3.77; 3.80
C 101.9 52.0 81.4 69.0 76.1 62.2
Glc D H 4.53 3.30 3.47 3.50 3.61 3.69; 3.88
C 105.7 74.0 76.9 70.6 75.5 66.8
GlcNAc E H 4.50 3.70 3.52 3.45 3.45 3.77; 3.94
C 103.1 56.7 75.2 71.0 77.0 61.8
Ser H 4.30 4.14; 4.14
C 178.2 54.3 68.1
Glu H 4.45 2.02; 2.14 2.51; 2.51
C 178.4 54.2 27.7 31.4
Ala H 4.42 1.42
C 175.9 51.0 17.7
Ala* H 4.31 1.42
C 178.4 51.0 17.7
*Indicates impurity.
doi:10.1371/journal.ppat.1002758.t002
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knowledge, this is the first time this technique is applied to study
bacterial glycoproteomics. The structure of the glycan used to
decorate these proteins in A. baumannii was determined by a
combination of MS and NMR techniques. The sugar was
determined to be a pentasaccharide of the formula b-GlcNAc3-
NAcA4OAc-4-(b-GlcNAc-6-)-a-Gal-6-b-Glc-3-b-GalNAc-S/T
(Fig S4). The glycan contains a terminal O-acetylated glucuronic
acid derivative that is negatively charged and has not previously
been described. A similar monosaccharide was found in
Pseudomonas aeruginosa and Bordetella pertussis [45]. Of the glyco-
proteins identified, only one (A1S_1193; MotB) has any
significant homology outside of the genus Acinetobacter, with the
remaining being annotated as hypothetical proteins. MotB has
homology with proteins such as Pal from Haemophilus influenzae
that have been shown to bind to peptidoglycan and stabilize the
outer membrane [46]. Functional characterization of A. baumannii
glycoproteins will be crucial to explain the phenotypes associated
with lack of glycosylation.
Biofilms are proposed to be a virulence factor that is associated
with increased antibiotic resistance, pathogenicity, and persistence
of a bacterial population [47–49]. We have found that O-
Figure 5. A. baumannii requires PglLAb for biofilm formation. A) Quantitative biofilm formation on polystyrene 96 well plates by strains
incubated without perturbation in LB at 30uC. The bars indicate the means for 8 replicates. The error bars indicate the standard deviation of the
means. Asterisks indicate significant differences (*, P,0.005 [t test; n=8]; **, P,0.001 [t test; n=8]). B) The median surface coverage after incubation
for 2 h in flow cell chambers of the WT, DpglL, DpglL pWH1266 and DpglL ppglL was determined by the COMSTAT software. For each strain at least
six micrographs from three independent experiments were analyzed. The error bars indicate the interquartile range. Asterisks indicate significant
differences (*, P,0.05 [Mann-Whitney U test; n=6]). C)–E) Image stacks of the WT, DpglL, DpglL pWH1266 and DpglL ppglL biofilms grown in flow
cells for 24 h were analyzed for the biomass as well as the maximum and average thickness using the COMSTAT software. Shown are the medians of
at least six image stacks from three independent experiments for each strain. The error bars indicate the interquartile range. Asterisks indicate
significant differences (*, P,0.05 [Mann-Whitney U test; n=6]). F) Shown are representative confocal laser scanning microscopy images of the WT
(upper row) and DpglL mutant (lower row) biofilms grown in flow cells for 24 h. The first three images represent horizontal (xy, large panel) and
vertical (xz and yz, side panels) projections at different z-levels (from left to right 0.2 mm, 3 mm and 6 mm). The fourth micrograph of each row
represents a three-dimensional image analyzed by the AMIRA software package of the WT and DpglL mutant biofilms, respectively.
doi:10.1371/journal.ppat.1002758.g005
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17978. Biofilm formation is a multistep process that involves an
initial weak association leading to an irreversible attachment,
which leads eventually to a complex maturation into sophisticated
superstructures [50]. We observed by flow cell and confocal
imaging that glycosylation enhances the initial attachment as well
as mature biofilm mass and density. It is tempting to speculate that
glycans of the glycoproteins may have a function in cell-to-cell
adhesion [51]. Further work will elucidate in which aspect protein
glycosylation is required for efficient biofilm formation.
The basic mechanisms of phagocytic cells are used in both
amoebae and mammalian macrophages. As an infection model,
the amoebae D. discoideum is considered a primitive macrophage.
D. discoideum cells were unable to predate on A. baumannii WT
lawns, but were able to efficiently predate on lawns of the
glycosylation-deficient bacteria. It is uncertain how protein O-
glycosylation protects A. baumannii from D. discoideum but we can
hypothesize that glycosylation may help in the inhibition of
phagocytosis by the amoebae, and/or prevent bacterial lysis by
reactive oxygen species produced by the amoebae [52]. Another
possibility is that glycosylation of certain proteins is required to
interfere with bacterial degradation and intracellular vesicle
transport and/or fusion, as shown for Legionella [53]. We also
analyzed if protein O-glycosylation plays a role in pathogenesis in
G. mellonella caterpillars. This model system has been recently
shown to recreate the mammalian humoral immune system, with
similar antimicrobial peptides, toll-like receptors, and the comple-
ment-like mechanism of melanization [54]. Similar to the D.
discoideum model, A. baumannii DpglL strain was unable to kill G.
mellonella. O-glycosylation could mediate killing of the larvae by
stabilizing the bacterial outer membrane of A. baumannii, which
could prevent killing by antimicrobial peptides. The negative
charges of the glycan chains could play a role in this process.
Alternatively, glycosylation could mask signals detected by the
larvae or prevent phagocytosis by G. mellonella haemocytes, among
other possibilities. The involvement of glycoproteins in virulence is
further supported by the demonstration that the DpglL strain is
outcompeted by wild type bacteria in a murine septicemia model.
Thus, our experiments showed that glycosylation is critical for
virulence in three different model systems. Further work using
strains carrying mutations in individual glycoproteins will help to
elucidate the exact role of protein glycosylation in pathogenesis.
Glycoproteins are usually immunodominant in bacteria, and
therefore, the glycoproteins identified in this study may be the base
of future vaccine formulations and diagnostic methods. The
prevalence of the O-glycosylation machinery in Acinetobacter sp.,
together with its role in virulence in the three different pathogenesis
models, suggest that protein O-glycosylation represents a novel
Figure 6. A. baumannii pathogenesis is dependent on PglLAb in
the Galleria mellonella virulence model. Representative data of
survival rate of 3 biological replicates of 10 individual G. mellonella
injected with 2.3161.13610
5 CFU of each strain in 5 mL of sterilized PBS
and incubated @ 37uC. Survival was assayed by response to touch or
discoloration. While killing by WT and DpglL-pglL was observed, no
killing was observed in the DpglL and 20% killing was observed in the
DpglL-pWH1266 strains up to 96 hours. No killing was observed in the
PBS injection control for the length of the experiment.
doi:10.1371/journal.ppat.1002758.g006
Figure 7. Characterization of A. baumannii ATCC 17978
pathogenesis in a murine septicemia model. A) Determination
of the LD50 of A. baumannii ATCC 17978. Groups of 5 mice were
injected with serial dilutions of A. baumannii WT to determine the LD50
which was calculated to be 6.49610
4 CFU @ 18 hrs post infection. B)
Murine competition septicemia between A. baumannii WT and DpglL.
Groups of 3 mice were injected with ,1:1 WT to DpglL CFU’s and were
sacrificed after 18 hrs, spleens were harvested, and bacterial load
determined.
doi:10.1371/journal.ppat.1002758.g007
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further dissemination of this emerging human pathogen, which has
become a major threat to our healthcare systems.
Materials and Methods
Bacterial strains, plasmids, growth conditions, and
antimicrobial agents
The bacterial strains and plasmids used in this study are listed in
Table 3. A. baumannii strains were grown in Luria Bertani broth/
agar at 37uC. The antibiotics ampicillin (Ap) 100 mg/mL,
gentamicin (Gm) 50 mg/mL, and tetracycline (Tc) 5 mg/mL were
added for selection as needed.
Construction of A. baumannii DpglL knockout and in
trans complementation
In order to create a DpglL via homologous recombination, we
cloned a ,3500 bp fragment consisting of ,1000 bp upstream
and downstream of A1S_3176 into pEXT20 using primers K/O
pglLfwd and K/O pglLrev from A. baumannii ATCC 17978 genomic
DNA (Table 3). The construct was subsequently subcloned from
pEXT20 into pFLP2. We then digested pFLP2-pglL with PsiI and
replaced A1S_3176 with a SmaI excised Gentamicin resistance
cassette (aacC1) from pSPG1 [55]. The plasmid pFLP2 does not
replicate in A. baumannii ATCC 17978. This final construct was
transformed into electro-competent A. baumannii WT cells and
selection for a single recombination event was analyzed using
media supplemented with gentamicin. Positive colonies were
grown in 5 mL LB at 37uC for 72 hours, with 1/1000 re-
inoculations into fresh LB media every 24 hour period. After
72 hours, the liquid culture was plated on LB agar supplemented
with gentamicin and 10% sucrose to select for a double
recombination event. Colony PCR using both internal and
external primers showed the allelic exchange of A1S_3176 with
aacC1, generating a knockout mutant of A. baumannii pglL.
SDS-PAGE and Periodic acid stain (PAS) analysis of
membrane extracts
Bacterial cultures were pelleted by centrifugation for 15 mins
at 10,0006g, washed with PBS, resuspended in PBS, and
subsequently lysed by French Press. Unbroken cells were pelleted
by centrifugation for 15 mins @ 5,0006g. The supernatant was
ultracentrifugated for 1 hr @ 100,0006g( 4 uC) to pellet cell
membrane. Samples were quantified by Bradford protein quan-
tification (Biorad) and analyzed on a 12% SDS-PAGE. The PAS
stain protocol used was previously described [56].
LPS extraction protocol
LPS was extracted according to Marolda et al [57]. Samples
were resuspended in 50 mLo fd H 20 and analyzed by Silverstain
on a 15% SDS-PAGE.
2D-DIGE analysis of A. baumannii membrane extracts
Lipid-free membranes were obtained for 2D-DIGE analysis
according to [27]. The material was resuspended in: 6.5 M Urea,
2.2 M thiourea, 1% w/v ASB-14, 5 mM Tris-HCl pH 8.8,
20 mM DDT, 0.5% IPG buffer. The samples were labeled using
CyDye minimal labeling protocol (Amersham Biosciences). A.
baumannii WT membranes were labeled with Cy5 and DpglL were
labeled with Cy3. Samples were quantified by 2D-Quant kit (GE
Healthcare) and 600 mg of each WT and DpglL membranes were
mixed in Destreak solution (GE Healthcare) to a final volume of
450 mL. 24 cm pH 3–11 NL IPG strips were simultaneously
rehydrated and sample loaded for 24 hrs at room temperature in
the dark. Isoelectric focusing was done using the Ettan IPGphor
system for a total of 56,000 Vhr in the dark. The strip was then
incubated in 10 mL of equilibration solution (2% SDS, 50 mM
Tris-HCl, 6 M Urea, 30% (v/v) glycerol, 0.002% bromophenol
blue) for 15 mins with 100 mg DTT and then 10 mL equilibration
solution with 250 mg iodoacetamide. The strip was then sealed
into a DALT 12.5 precast gel with 0.5% agarose. The system was
run at 2.5 W/gel for 30 mins, the 17 W/gel until the dye front
exited the bottom. The gel was visualized using FLA-5000
(FujiFilm) and the images analyzed by ImageQuant 5.0. The gel
was subsequently stained with Coomassie brilliant blue, and
individual spots excised and prepared for mass spectrometry.
MALDI-TOF/TOF MS and MS/MS analysis of glycoproteins
Samples were in gel tryptically-digested and the peptides were
desalted using C18 Zip-Tips and eluted with 60% CH3CN/40%
Table 3. List of strains, plasmids, and primers used in this work.
Strains Reference
A. baumannii ATCC 17978 [68]
A. baumannii ATCC 17978 DpglL This work
Plasmid Reference
pEXT20 [69]
pWH1266 [70]
pFLP2 [71]
pSPG1 [55]
Primers Sequence (59-39)
pglLfwd EcoRI gcgaattcatgttttctagtgaaatgggtgcctttgcagcag
pglLrev XbaI 10His gaggaattacattcggctttggatacaccaccaccaccaccaccaccaccaccactaatctagaaatt
aacC1int rev catcgcgcttgctgccttcgaccaagaagc
K/O pglLfwd EcoRI gagaattcatgaatgcacaaaaaggttttacattaattgaactcatg
K/O pglLrev XbaI ccgagttgttcaattccccaatcattaaacatacgagtctagatgt
doi:10.1371/journal.ppat.1002758.t003
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steel or Bruker Daltonics MTP AC600 Anchorchip target plate and
air dried. 1 mL for ground steel and 0.4 mL for the AC600 target of
2,5-dihydroxybenzoic acid (DHB, 10 mg/mL in 30% H2O, 70%
CH3CN) was spotted on top and allowed to dry. Mass spectra were
obtained in the positive mode of ionization using a Bruker Daltonics
(Bremen, GmbH) UltrafleXtreme MALDI TOF/TOF mass spec-
trometer. The FlexAnalysis software provided by the manufacturer
was used for analysis of the mass spectra.The MS/MS spectra were
obtained manually. The exact m/z used as the precursor m/z for
MS/MS was determined first on a Bruker Daltonics (Billerica, MA)
Apex Qe MALDI FTICR MS instrument and the MS/MS
spectrum was automatically re-calibrated based upon this m/z.
MALDI TOF-TOF MS characterization of the A. baumannii
O-glycan from membrane extracts
Lipid free membrane extracts were digested for 72 hrs at 37uC
with 2 mL Pronase E (20 mg/mL) being freshly added every
24 hrs. Glycosylated peptides were enriched using Active Char-
coal Micro SpinColumn (HARVARD Apparatus) Briefly, the
column was prewashed 36with 400 mL of 0.1% TFA in of 80%
ACN and 20% ddH2O and centrifuged at 500 RCF for
2 minutes. The column was equilibrated 36 using 400 mLo f
H2O. The sample was loaded 36at 500 RCF for 2 minutes. The
column was washed 26with 200 mL of ddH2O at 500 RCF for
2 minutes. The glycan was eluted 36with 100 mL 0.1% TFA in
50% ACN and 50% H2O at 1000 RCF for 2 minutes. The
sample was dried by vacuum centrifugation and analyzed by
MALDI-TOF/TOF MS and MS/MS.
Purification of glycans for NMR analysis
For NMR analysis glycoproteins were digested with a large excess
of proteinase K at pH 8 (adjusted by addition of ammonia)at 37uCf o r
48 hours. Products of digestion or free oligosaccharides were
separated on Sephadex G-15 column (1.5660 cm) and each fraction
eluted before salt peak was dried and analyzed by
1HN M R .F r a c t i o n s
containing desired products were separated by anion exchange
chromatography on Hitrap Q column (5 mL size, Amersham) and
glycan eluted with a linear gradient of NaCl (0–1 M, 1 h). Desalting
was performed on Sephadex G15 prior to analysis by NMR.
NMR spectroscopy analysis
NMR experiments were carried out on a Varian INOVA
600 MHz (
1H) spectrometer with 3 mm gradient probe at 25uC
with acetone internal reference (2.225 ppm for
1H and 31.45 ppm
for
13C) using standard pulse sequences DQCOSY, TOCSY
(mixing time 120 ms), ROESY (mixing time 500 ms), HSQC and
HMBC (100 ms long range transfer delay). AQ time was kept at
0.8–1 sec for H-H correlations and 0.25 sec for HSQC, 256
increments was acquired for t1. Assignment of spectra was
performed using Topspin 2 (Bruker Biospin) program for spectra
visualization and overlap. Monosaccharides were identified by
COSY, TOCSY and NOESY cross peak patterns and
13C NMR
chemical shifts. Aminogroup location was concluded from high
field signal position of aminated carbons (CH at 45–60 ppm).
Connections between monosaccharides were determined from
transglycosidic NOE and HMBC correlations.
Protease digestion and enrichment of glycopeptides by
zwitterionic hydrophilic interaction chromatography
(ZIC-HILIC)
Dried membrane protein-enriched fractions were resuspended
in 6 M urea, 2 M thiourea, 40 mM NH4HCO3. Samples were
reduced, alkylated, digested with Lys-C (1/200 w/w) and then
trypsin (1/50 w/w) as described previously [20]. Digested samples
were then dialyzed against ultra-pure water overnight using a Mini
Dialysis Kit with a molecular mass cut off of 1000 Da (Amersham
Biosciences, Buckinghamshire, UK) and on completion were
collected and lyophilized. ZIC-HILIC enrichment was performed
according to [20] with minor modifications. Micro-columns
composed of 10 mm ZIC-HILIC resin (Sequant, Umea ˚, Sweden)
were packed into P10 tips on a stage of Empire C8 material
(Sigma) to a bed length of 0.5 cm and washed with ultra-pure
water prior to use. Dried digested samples were resuspended in
80% acetonitrile (ACN), 5% formic acid (FA) and insoluble
material removed by centrifugation at 20,0006g for 5 min at 4uC.
Samples were adjusted to a concentration of 2 mg/mL and 100 mg
of peptide material loaded onto a column and washed with 10 load
volumes of 80% ACN, 5% FA. Peptides were eluted with 3 load
volumes of ultra-pure water into low-bind tubes and concentrated
using vacuum centrifugation.
Identification of glycopeptides using reversed phase LC-
MS and HCD MS-MS
ZIC-HILIC fractions were resuspended in 0.1% FA and loaded
onto a Acclaim PepMap 100 mm C18 Nano-Trap Column
(Dionex Corporation, Sunnyvale, CA) for 10 min using a
UltiMate 3000 intelligent LC system (Dionex Corporation).
Peptides were eluted and separated on 20 cm, 100 mm inner
diameter, 360 mm outer diameter, ReproSil – Pur C18 AQ 3 mm
(Dr. Maisch, Ammerbuch-Entringen, Germany) in house packed
column. Enriched peptides derived from tryptic digests were
analysed using an LTQ-Orbitrap Velos (Thermo Scientific, San
Jose CA). Samples were eluted using a gradient from 100% buffer
A (0.5% acetic acid) to 40% buffer B (0.5% acetic acid, 80%
MeCN) over 120 mins at a constant flow of 200 nL/min enabling
the infusion of sample in the instrument using ESI. The LTQ-
Orbitrap Velos was operated using Xcalibur v2.2 (Thermo
Scientific) with a capillary temperature of 200uC in a data-
dependent mode automatically switching between MS ion trap
CID and HCD MS-MS. For each MS scan, the three most
abundant precursor ions were selected for fragmentation with
CID, activation time 30 ms and normalized collision energy 35,
followed by HCD, activation time 30 ms and normalized collision
energy 45. MS resolution was set to 60,000 with an ACG of 1e
6,
maximum fill time of 500 ms and a mass window of m/z 600 to
2000. MS-MS fragmentation was carried out with an ACG of 3e
4/
2e
5 for CID/HCD and maximum fill time of 100 ms/500 ms
CID/HCD. For HCD events an MS resolution of 7500 was set. A
total of six HILIC enrichments were performed and analysis by
the above protocol.
Database interrogation of identified glycopeptides
Raw files were processed within Proteome Discover version 1.0
Build 43 (Thermo Scientific) to generate .mgf files. To identify
possible glycopeptides within exported scans, the MS-MS module
of GPMAW 8.2 called ‘mgf graph’ was utilized. This module
allowed the identification of all scan events within the generated
.mgf files containing the diagnostic oxonium m/z 301.10 ion.
These scan events were manually inspected and identified as
possible glycopeptides based on the presence of the deglycosylated
peptide ion with a tolerance of 20 ppm. To facilitate glycopeptide
assignments from HCD scan events, ions below the mass of the
predicted deglycosylated peptides were extracted with Xcalibur
v2.2 using the Spectrum list function. Ions with a deconvoluted
mass above the deglycosylated peptide mass and ions correspond-
ing to known carbohydrate oxonium ions such as 204.08 and
O-glycosylation in Acinetobacter baumannii
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processing of ETD data [58,59]. MASCOT v2.2 searches were
conducted via the Australasian Proteomics Computational Facility
(www.apcf.edu.au) with the Proteobacteria taxonomy selected.
Searches were carried out with a parent ion mass accuracy of
20 ppm and a product ion accuracy of 0.02 Da with no protease
specificity, instrument selected as MALDI-QIT-TOF (use of this
instrumentation setting was due to the observation of multiple
internal cleavage products, extensive NH3 and H2O loss from a, b,
y ions, which are all included within this scoring setting) as well as
the fixed modification carbamidomethyl (C) and variable modi-
fications, oxidation (M) and deamidation (N). An ion score cut-off
of 20 was accepted and all data were searched with the decoy
setting activated generating a zero false positive rate generated
against the decoy database.
Biofilm analysis using 96 well polystyrene plates
Cultures were grown overnight and re-inoculated at an OD600
0.05 in 100 mL into replicates in a 96 well polystyrene plate
(Costar). The cultures were subsequently grown without shaking
for 48 hours at 30uC. Bacterial growth was determined by
measuring the absorbance at OD600 nm. The cultures were
removed and the wells washed with ddH20, followed by the
addition of 100 mL of 1% crystal violet in ethanol to stain the cells.
The plate was incubated for 30 mins with gentle agitation, then
thoroughly washed with ddH20, and the stained biofilms
solubilized with 100 mL of 2% SDS for 30 minutes with gentle
agitation. The amount of biofilm formed was quantified by
measuring the absorbance at OD580 nm. The data was normalized
using the ratio between OD580/OD600.
Flow cell biofilm experiments, fluorescent staining and
confocal laser scanning microscopy
Flow cell experiments and fluorescent staining were performed
as described previously by Seper et al. [60]. Briefly, the
respective overnight cultures were adjusted to OD600=0.1 using
50-fold diluted LB (2%). Per channel, approximately 250 mlo f
the dilutions were inoculated. After static incubation for 2 h,
flow of pre-warmed 2% LB (37uC) was initiated (3 ml/h).
Biofilms were allowed to form for a time period of 24 h and were
stained with SYTO 9 (Invitrogen) for visualization. Images of
attached bacteria or biofilms were acquired using a Leica SP5
confocal microscope (Leica Microsystems, Mannheim, Germany)
with spectral detection and a Leica HCX PL APO CS 406 oil
immersion objective (NA 1.25). For the SYTO 9 signal, the
excitation wavelength was set at 488 nm and fluorescence
emission was detected between 500–530 nm. Optical sections
were recorded in 0.2 mm steps. For two-dimensional image
visualization the Leica LAF and for three-dimensional image
processing the AMIRA software (direct volume rendering with
VOLREN module) was used. Quantification of image stacks was
performed using COMSTAT (http://www.comstat.dk) [61] (M.
Vorregaard et al., pers. comm.). For COMSTAT analysis at
least six image stacks from three independent experiments were
used.
Dictyostelium discoideum virulence assay
This assay was performed essentially as described by [62].
Briefly, midlogarithmic cultures of D. discoideum were mixed with
overnight cultures of bacteria to a final concentration of 1610
3
amoebae ml
21. 0.2 ml of the suspension was then plated on SM/5
agar containing 1% ethanol. Plates were incubated at room
temperature and monitored for D. discoideum plaques for 3–5 days.
Wild type bacteria are toxic to the amoebae. Appearance of
plaques indicates attenuation.
Galleria mellonella virulence assay
This assay was performed as previously described [32]. Galleria
mellonella larvae were bred in sterile conditions at 37uC by Dr.
Andrew Kedde (University of Alberta). After injection of bacteria,
caterpillars were incubated at 37uC, and the number of dead
caterpillars was scored every 5 hours. Caterpillars were considered
dead when they were nonresponsive to touch. This experiment is a
representative of 3 biological replicates.
Murine bacterial competition model assay
A murine model of disseminated sepsis using BALB/c mice (16–
20 grams) was used for bacterial challenge [63,64]. A. baumannii
strains were grown for 18 h at 37uC in Luria broth withappropriate
antibiotics and adjusted to the appropriate concentration in
physiologic saline.Inoculums were prepared by mixingthe bacterial
suspensions 1:1 (v:v) with a 10% solution (w/v) of porcine mucin
(Sigma, St. Louis, MO) which increases the infectivity of A.
baumannii, allowing for a lower concentration of bacteria to be used
[65–67]. Mice were injected intraperitoneally with 0.2 ml of the
bacterial/mucin inoculums. Bacterial concentrations were deter-
mined by plating dilutions on Luria agar. The wild type strain lethal
dose for 50% of animals was determined by the limit test where
groups of 5 mice were infected with dilutions of bacteria, at a range
of concentrations within 2 logs of a concentration of bacteria that
had previously been shown to be lethal with this species of bacteria
using a disseminated sepsis model.
An in vivo competition assay was used to compare fitness
between the wt and DpglL strains [37–39]. Liquid cultures
containing individual strains were diluted and plated on LB agar.
Mixed inoculums were established by mixing equal proportions of
strains based on the OD600. Once mixed the inoculums were
serially diluted and plated on LB agar and LB agar with
gentamycin to select for the DpglL. The expected ratio of CFU
on LB compared to CFU on LB with gentamycin was 2:1.
For bacterial competition experiments in vivo an animal model
of sepsis was used. Groups of 3 BALB/c female 16–20-g mice were
inoculated intraperitoneally with 1610
5 CFUs of mixed inocu-
lums (50% of each strain). Groups of 3 mice were sacrificed at 18 h
after inoculation. Mice at 18 hours of infection were showing
clinical signs of illness and were often moribund. Spleens were
aseptically removed, weighed, and homogenized via passage
through a cell strainer (BD falcon 70 um cell strainer) in
physiological saline before plating serial log dilutions on Luria
agar plates for bacterial quantification. If the two strains had equal
fitness in vivo the ratio established prior to infection should be
maintained.
Ethics statement
All procedures and experiments involving animals (mice) were
approved by the Institutional Animal Care Committee of Defence
Research and Development Canada Suffield (protocol # CWS-
08-1-1-1), and were in accordance with guidelines from the
Canadian Council of Animal Care.
Supporting Information
Figure S1 Analysis of LPS extraction of A. baumannii
strains resolved by SDS-PAGE and visualized by Silver-
stain. Samples were as follows: lane 1 WT; lane 2 DpglL, lane 3
DpglL, pWH1266-pglL,4 - DpglL, pWH1266 control.
(TIF)
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whole cell extracts of A. baumannii ATCC 17978 strains.
Each lane was loaded with 0.2 OD600 of sample, and probed with
OmpA monoclonal antibody with no observable differences
between the WT and DpglL.
(TIF)
Figure S3 MALDI-TOF/TOF MS/MS fingerprint analy-
sis of glycosylated peptides in A. baumannii. A) Sequenc-
ing of the peptide SAGDQAASDIATATDNASAK from the
parental peak 2895.24 Da demonstrates the peptide matches the
expected sequence of A1S_3626. B) Sequencing of the peptide
ETPKEEEQDKVETAVSEPQPQKPAK from the parental
peak 2822.33 Da demonstrates the peptide matches the expected
sequence of A1S_3744.
(TIF)
Figure S4
1H:
13C HSQC 2D NMR spectra of the A.
baumannii O-glycan. NMR data for the A. baumannii O-glycan
(D2O, 28uC, 600 MHz). NAc: 1.95/23.0; 2.00/23.3; 2.04/23.5;
2.04/23.5 ppm, all C-1 at 175.9 ppm. OAc: 2.06/21.3,
174.0 ppm. The amino acids attached to the pentasaccharide
were determined to be S-E-A (order not determined). * indicates
impurity.
(TIF)
Figure S5 Dictyostelium discoideum plaque assay com-
paring virulence of A. baumannii strains. Bacteria were
mixed with ,500 amoebae, plated on SM/5 agar with 1%
ethanol, and incubated at room temperature for 72 hours to allow
for plaque formation. Results are representative of four indepen-
dent experiments with 1 representing WT and 2 representing
DpglL.
(TIF)
Figure S6 Protein glycosylation appears to be highly
conserved in A. baumannii clinical isolates. A) 10 mgo f
membrane extract from A. baumannii clinical isolates obtained from
the University of Alberta Hospital were resolved by SDS-PAGE
and detection of carbohydrates was performed by PAS stain. 8/8
isolates have a similar PAS reactive band to A. baumannii ATCC
17978. Isolates were putatively identified by sequencing 16S
rDNA and recA and are as follows: lane 1 A. calcoaceticus, lane 2 A.
calcoaceticus, lane 3 A. pittii, lane 4 A. pittii, lane 5 A. nosocomialis, lane
6 A. nosocomialis, lane 7 A. junii, lane 8 A. baumannii. B) Phylogenetic
tree of hypothetical O-OTases of Acinetobacter sp. and known O-
OTases and O-antigen ligases. Protein identification numbers are
as follows: N. meningitidis M58 PglL (NP_273640.1); N. gonorrhoeae
MS11 PglO (ZP_04726765.1); P. aeruginosa PAO1 PilO
(AAP43787.1); A. baumannii ATCC 17978 (YP_001086175.1); A.
baumannii AB900 (ZP_04661261.1); A. baumannii ACICU
(YP_001848035.1); A. baumannii ATCC 19606 (ZP_05829147.1),
A. baumannii ATCC 19606 Ligase (YP_001713790.1); A. baumannii
SDF (YP_001705998.1); A. baumannii 1656-2 (ADX05061.1); A.
baumannii 6014059 (ZP_08441731.1); A. calcoaceticus RUH2202
(ZP_06059388.1); A. baumannii AYE (YP_001712289.1); A. bau-
mannii AB0057 (YP_002320930.1); A. calcoaceticus PHEA-2
(ADY83231.1); Acinetobacter sp. SH024 (ZP_06693023.1); Acineto-
bacter sp. DR1 (YP_003730587.1); Acinetobacter sp. RUH2624
(ZP_05825054.1); Acinetobacter sp. ATCC_2724 (ZP_03824224.1);
A. junii SH205 (ZP_06066893.1); A. haemolyticus ATCC 19194
(ZP_06729056.1); Acinetobacter sp. ADP1 ACIAD0103 (YP_
044903.1); Acinetobacter sp. ADP1 ACIAD3337 (YP_047828.1); A.
lwoffii SH145 (ZP_06070298.1); Klebsiella pneumoniae WaaL
(AAX20101.1). Phylogenetic tree was built using http://www.
phylogeny.fr/version2_cgi/index.cgi (50).
(TIF)
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